Brian Seal

Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US

Apar Kishor Ganti, Alyssa Klein, Ion Cotarla et al. · JAMA Oncology · 2021 · 693 citations · Full text

Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer

Eberechukwu Onukwugha, Candice Yong, Arif Hussain et al. · BMC Medical Research Methodology · 2014 · 584 citations · Full text

The Cost of Poor Sleep: Workplace Productivity Loss and Associated Costs

Mark R. Rosekind, Kevin B. Gregory, Melissa M. Mallis et al. · Journal of Occupational and Environmental Medicine · 2010 · 373 citations

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer

Amy J. Davidoff, Mei Jie Tang, Brian Seal et al. · Journal of Clinical Oncology · 2010 · 290 citations · Full text

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part I

Joel W. Hay, Jim Smeeding, Norman V. Carroll et al. · Value in Health · 2009 · 105 citations · Full text

Substance Abuse, Cost-effectiveness Analysis, Health Economics +13